PLEOPHARMA, INC. research brief
CIK 1801323
Generated Nov. 18, 2026, 7:45 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: PHOENIXVILLE Pennsylvania. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Aug. 10, 2026 · D · 0001801323-26-000001 · Source evidence
Reported offering amount: 15000000 USD. Reported amount sold: 5500000 USD.
- Aug. 8, 2025 · D · 0001801323-25-000003 · Source evidence
Reported offering amount: 36240000 USD. Reported amount sold: 6150000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “PLEOPHARMA, INC. research brief,” CIK 1801323, retrieved Nov. 18, 2026, 7:45 a.m.. Cite the specific accessions used. No amounts have been summed.